As on 23 Oct 2026
Invesco India Pharma and Healthcare Fund
EquityNAV
₹ 8.95
CAGR (3 Years)
%
AUM (Cr)
₹ 435.52
Risk
Very High Risk
About Invesco India Pharma and Healthcare Fund
To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Breakdown of this Fund
Debt Others
12.99%
Healthcare
45.62%
Pharmaceuticals
41.39%